Correction: In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity

Código QR

Correction: In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity

Guardado en:

Detalles Bibliográficos
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/b70a7ff9ff084f94b925b3ac4b29ca26
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity
por: Marie-Claude Bourgeois-Daigneault, et al.
Publicado: (2021)

Experimental evolution of an oncolytic vesicular stomatitis virus with increased selectivity for p53-deficient cells.
por: Raquel Garijo, et al.
Publicado: (2014)

Mechanisms that allow vaccination against an oncolytic vesicular stomatitis virus-encoded transgene to enhance safety without abrogating oncolysis
por: Amanda W. K. AuYeung, et al.
Publicado: (2021)

Structure of the vesicular stomatitis virus N⁰-P complex.
por: Cédric Leyrat, et al.
Publicado: (2011)

Phase Transitions Drive the Formation of Vesicular Stomatitis Virus Replication Compartments
por: Bianca S. Heinrich, et al.
Publicado: (2018)

The phosphoinositide 3-kinase inhibitor ZSTK474 increases the susceptibility of osteosarcoma cells to oncolytic vesicular stomatitis virus VSVΔ51 via aggravating endoplasmic reticulum stress
por: Jinqiong Jiang, et al.
Publicado: (2021)

Vesicular Stomatitis Virus Chimeras Expressing the Oropouche Virus Glycoproteins Elicit Protective Immune Responses in Mice
por: Sarah Hulsey Stubbs, et al.
Publicado: (2021)

Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever
por: Sergio E. Rodriguez, et al.
Publicado: (2019)

Correction: IL-21 arming potentiates the anti-tumor activity of an oncolytic vaccinia virus in monotherapy and combination therapy
Publicado: (2021)

Plasma membrane phosphatidylinositol 4,5 bisphosphate is required for internalization of foot-and-mouth disease virus and vesicular stomatitis virus.
por: Angela Vázquez-Calvo, et al.
Publicado: (2012)

Vesicular stomatitis virus infection promotes immune evasion by preventing NKG2D-ligand surface expression.
por: Helle Jensen, et al.
Publicado: (2011)

Transmitted/founder simian immunodeficiency virus envelope sequences in vesicular stomatitis and Semliki forest virus vector immunized rhesus macaques.
por: Ratish Gambhira, et al.
Publicado: (2014)

Intracellular Replication Inhibitory Effects of Tea Tree Oil on Vesicular Stomatitis Virus and Anti-inflammatory Activities in Vero Cells
por: Qi Shao, et al.
Publicado: (2021)

Recoding of the Vesicular Stomatitis Virus L Gene by Computer-Aided Design Provides a Live, Attenuated Vaccine Candidate
por: Bingyin Wang, et al.
Publicado: (2015)

Two Point Mutations in Old World Hantavirus Glycoproteins Afford the Generation of Highly Infectious Recombinant Vesicular Stomatitis Virus Vectors
por: Megan M. Slough, et al.
Publicado: (2019)

IL-21 arming potentiates the anti-tumor activity of an oncolytic vaccinia virus in monotherapy and combination therapy
por: Xiaoyan Zhang, et al.
Publicado: (2021)

The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors
por: Kyle M. Pierce, et al.
Publicado: (2021)

Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
por: Zuqiang Liu, et al.
Publicado: (2017)

Choindroitinase ABC I-mediated enhancement of oncolytic virus spread and anti tumor efficacy: a mathematical model.
por: Yangjin Kim, et al.
Publicado: (2014)

Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy
por: Masmudur M. Rahman, et al.
Publicado: (2021)

The Use of Oncolytic Viruses in the Treatment of Multiple Myeloma
por: Georgia Stewart, et al.
Publicado: (2021)

The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy
por: Xin Xie, et al.
Publicado: (2022)

An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses
por: Guan Wang, et al.
Publicado: (2020)

New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy
por: Lundstrom K
Publicado: (2018)

Author Correction: Smac mimetics and oncolytic viruses synergize in driving anticancer T-cell responses through complementary mechanisms
por: Dae-Sun Kim, et al.
Publicado: (2018)

Multi-Omics Analysis of Glioblastoma Cells’ Sensitivity to Oncolytic Viruses
por: Anastasiya V. Lipatova, et al.
Publicado: (2021)

Oncolytic Virotherapy

Oncolytic Virotherapy
Publicado: (2016)

The importance of curve severity, type and instrumentation strategy in the surgical correction of adolescent idiopathic scoliosis: an in silico clinical trial on 64 cases
por: Fabio Galbusera, et al.
Publicado: (2021)

PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance
por: Luke Russell, et al.
Publicado: (2018)

Plant stomatal conductance determined transpiration and photosynthesis both contribute to the enhanced negative air ion (NAI)
por: Zhenzhen Zhang, et al.
Publicado: (2021)

An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma
por: Bo Xu, et al.
Publicado: (2021)

Anti-tumor activity of a miR-199-dependent oncolytic adenovirus.
por: Elisa Callegari, et al.
Publicado: (2013)

A potential bat adenovirus-based oncolytic virus targeting canine cancers
por: Hiromichi Matsugo, et al.
Publicado: (2021)

Oncolytic virus-derived type I interferon restricts CAR T cell therapy
por: Laura Evgin, et al.
Publicado: (2020)

Directed evolution generates a novel oncolytic virus for the treatment of colon cancer.
por: Irene Kuhn, et al.
Publicado: (2008)

Eliciting an immune-mediated antitumor response through oncolytic herpes simplex virus-based shared antigen expression in tumors resistant to viroimmunotherapy
por: Chun-Yu Chen, et al.
Publicado: (2021)

Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy
por: Julia Niemann, et al.
Publicado: (2019)

Co-Infection of Bovine Papular Stomatitis Virus, Rotavirus and Cryptosporidium Spp. in a Calf
por: Yesari Eroksuz, et al.
Publicado: (2020)

Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors
por: Amanda Rosewell Shaw, et al.
Publicado: (2021)